Literature DB >> 26487

Sphingomyelinase activity levels in human peripheral blood leukocytes, using [3H]sphingomyelin as substrate: study of heterozygotes and homozygotes for Niemann-Pick disease variants.

D Zitman, S Chazan, C Klibansky.   

Abstract

Patients and heterozygous carriers of Niemann-Pick disease types A and B as well as the primary (genetic) sea-blue histiocyte syndrome were investigated for their leukocyte sphingomyelinase activity. In parallel, glucocerebrosidase activity was determined in all cases studied. [3H]Sphingomyelin and [14C]glucocerebroside served as substrates for sphingomyelinase and glucocerebrosidase activity measurements, respectively. Conditions for these enzymes' assays are discussed. Sphingomyelinase activity was completely absent in three cases of Niemann-Pick disease type A and significantly diminished in one patient with Niemann-Pick disease type B and two with the sea-blue histiocyte syndrome. Sphingomyelinase activity in obligatory heterozygotes of all variants investigated represented about 40 to 70% of normal activity. Nevertheless, some overlapping with normal values occasionally occurred. Interestingly, glucocerbrosidase activity was elevated in patients with Niemann-Pick disease variants.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26487     DOI: 10.1016/0009-8981(78)90455-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Chemical studies on postmortem tissues from an infant with a sphingomyelin storage disorder.

Authors:  S F Donaghey; D N Raine; J E Crossley
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

2.  Clinical and biochemical study of a child with the non-neuronopathic-Type B form of Niemann-Pick disease.

Authors:  D Reich; A Kedar; C Klibansky
Journal:  Eur J Pediatr       Date:  1979-05-18       Impact factor: 3.183

3.  Molecular basis for a new bovine model of Niemann-Pick type C disease.

Authors:  Shernae A Woolley; Emily R Tsimnadis; Cor Lenghaus; Peter J Healy; Keith Walker; Andrew Morton; Mehar S Khatkar; Annette Elliott; Ecem Kaya; Clarisse Hoerner; David A Priestman; Dawn Shepherd; Frances M Platt; Ben T Porebski; Cali E Willet; Brendon A O'Rourke; Imke Tammen
Journal:  PLoS One       Date:  2020-09-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.